4 completed. 4 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 4 | Completed 4 |
Follow Aspergillosis: new trials by email Literature Review of Aspergillosis trials Research Report on Aspergillosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Posaconazole for the Prevention of Influenza-associated Aspergillosis in Critically Ill Patients SOC +Posaconazole 18 MG/ML (milligram/milliliter), standard of care (SOC) - Aspergillosis; Pulmonary, Invasive (Etiology) | Phase 4 | Completed | Universitaire Ziekenhuizen KU Leuven | 88 | 2017-12-27 | 2025-04-08 |
| Efficacy Of Itraconazole In Chronic Cavitary Pulmonary Aspergillosis Itraconazole, treatment in cavitary pulmonary aspergillosis - Chronic Cavitary Pulmonary Aspergillosis | Phase 4 | Completed | Post Graduate Institute of Medical Education and Research, Chandigarh | 31 | 2010-07-01 | 2012-02-22 |
| A Study To Assess The Anidulafungin And Voriconazole Concentration In Lung Following Intravenous Administration In Healthy Subjects anidulafungin and voriconazole - Aspergillosis, Candidemia | Phase 4 | Completed | Pfizer | 24 | 2008-09-01 | 2010-02-09 |
| A Study of the Efficacy and Safety of Voriconazole for the Treatment of Fungal Infections Voriconazole - Candidiasis, Cryptococcosis | Phase 4 | Completed | Pfizer | 7 | 2003-04-01 | 2011-05-16 |
Candidemia (1) · Candidiasis (1) · Cryptococcosis (1) · Influenza, Human (1) · Mycetoma (1) · Mycoses (1)
Bacterial Infections and Mycoses (4) · Infections (4) · Mycoses (3) · Actinomycetales Infections (1) · Bacterial Infections (1) · Candidiasis (1) · Candidiasis, Invasive (1) · Dermatomycoses (1) · Fungemia (1) · Gram-Positive Bacterial Infections (1) · Inflammation (1) · Invasive Fungal Infections (1) · Nocardia Infections (1) · Orthomyxoviridae Infections (1) · Pathologic Processes (1)
Voriconazole (2) · Anidulafungin (1) · Itraconazole (1) · Magnesium (1) · Standard of Care (1) · Therapeutics (1) · posaconazole (1)
Pfizer (2) · Post Graduate Institute of Medical Education and Research, Chandigarh (1) · Universitaire Ziekenhuizen KU Leuven (1)
Belgium (1) · France (1) · India (1) · Netherlands (1) · Taiwan (1) · United States (1)
Joost Wauters, Phd (1) · Paul Verweij, Phd (1)